iRHOM2 is a critical pathogenic mediator of inflammatory arthritis

Journal of Clinical Investigation

Volumn 123, Issue 2, 2013, Pages 928-932

  Issuree, Priya Darshinee A ^a,b   Maretzky, Thorsten ^a   McIlwain, David R ^c,d,e   Monette, Sébastien ^f   Qing, Xiaoping ^a   Lang, Philipp A ^e   Swendeman, Steven L ^a   Park Min, Kyung Hyun ^a   Binder, Nikolaus ^a   Kalliolias, George D ^a   Yarilina, Anna ^a   Horiuchi, Keisuke ^g   Ivashkiv, Lionel B ^a,b   Mak, Tak W ^c,d   Salmon, Jane E ^a,b   Blobel, Carl P ^a,b,h  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f Tri Institutional Laboratory of Comparative Pathology   (United States)

^g KEIO UNIVERSITY   (Japan)

^h Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; IRHOM2 PROTEIN; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; ENZYME REGULATION; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84873349403     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66168     Document Type: Article

References (24)

1. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science. 2012;335(6065):225-228.
2. McIlwain DR, et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science. 2012;335(6065):229- 232.
3. Siggs OM, et al. iRhom2 is required for the secretion of mouse TNFalpha. Blood. 2012;119(24):5769-5771.
4. Black R, et al. A metalloprotease disintegrin that releases tumour-necrosis factor-α from cells. Nature. 1997;385(6618):729-733.
5. Horiuchi K, et al. Cutting edge: TNF-α-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol. 2007;179(5):2686-2689.
6. Moss ML, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-recrosis factor-α. Nature. 1997;385(6618):733-736.
7. Peschon JJ, et al. An essential role for ectodomain shedding in mammalian development. Science. 1998;282(5392):1281-1284.
8. Blobel CP. ADAMs: key players in EGFR-signaling, development and disease. Nat Rev Mol Cell Biol. 2005;6:32-43.
9. Blaydon DC, et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med. 2011;365(16):1502-1508.
10. Franzke CW, et al. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med. 2012;209(6):1105-1119.
11. Chalaris A, et al. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med. 2010;207(8):1617-1624.
12. Brandl K, et al. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc Natl Acad Sci U S A. 2010;107(46):19967-19972.
13. Ji H, et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med. 2002;196(1):77-85.
14. Kitaura H, et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol. 2004;173(8):4838-4846.
15. Ji H, et al. Arthritis critically dependent on innate immune system players. Immunity. 2002;16(2):157-168.
16. Maretzky T, Zhou W, Huang XY, Blobel CP. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17. Oncogene. 2011;30(5):611-618.
17. Tape CJ, et al. Cross-domain inhibition of TACE ectodomain. Proc Natl Acad Sci U S A. 2011;108(14):5578-5583.
18. Durandy A, et al. Intravenous immunoglobulins-understanding properties and mechanisms. Clin Exp Immunol. 2009;158(suppl 1):2-13.
19. Baumann U, et al. A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. J Immunol. 2000;164(2):1065-1070.
20. Hopken UE, Lu B, Gerard NP, Gerard C. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J Exp Med. 1997;186(5):749-756.
21. Hu X, et al. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol. 2002;3(9):859-866.
22. Maretzky T, et al. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. Nat Commun. 2011;2:229.
23. Choe JY, Crain B, Wu SR, Corr M. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med. 2003;197(4):537-542.
24. Antoniv TT, Ivashkiv LB. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 2006;54(9):2711-2721.